Keywords: Merck & Co, Third-quarter 2010 financial results
Merck & Co 3rd-qtr 2010 profit beats forecasts, but legal provisions decimate earnings
Article | 01 November 2010
US drug giant Merck & Co (NYSE: MRK) reported financial results for the third quarter of 2010 showing that worldwide sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
